Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ligand Pharmaceuticals Inc (LGND)  
$115.72 2.50 (2.11%) as of 4:30 Wed 6/25


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 19,290,000
Market Cap: 2.23(B)
Last Volume: 562,071 Avg Vol: 557,528
52 Week Range: $77.82 - $129.9
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    : 12.3
Insider 6 Months    : 12.3
Insider 3/6 Months : 24.9
Guru Rank Number :  196
Guru Rank Value     : 7.3
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Co. employs research technologies such as antibody discovery technologies, ion channel discovery technology, Pseudomonas fluorescens protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. Co.'s collaboration partners and licensees have programs in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 11,010 11,010 13,510 17,510
Total Buy Value $1,156,546 $1,156,546 $1,400,027 $1,637,556
Total People Bought 2 2 2 2
Total Buy Transactions 2 2 3 4
Total Shares Sold 2,000 7,000 69,435 113,293
Total Sell Value $218,313 $793,462 $7,253,036 $10,956,676
Total People Sold 1 2 4 6
Total Sell Transactions 3 4 15 24
End Date 2025-03-28 2024-12-25 2024-06-26 2023-06-27

   
Records found: 538
  Page 1 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Reardon Andrew CLO & Secretary   •       –      –    2025-06-23 4 S $114.08 $57,042 D/D (500) 31,903 -3%     
   Reardon Andrew CLO & Secretary   •       –      –    2025-06-10 4 S $114.54 $57,271 D/D (500) 32,403 -4%     
   Haas Jason Director   –       •      –    2025-06-06 4 A $0.00 $0 D/D 1,209 6,606     -
   Aryeh Jason Director   –       •      –    2025-06-06 4 A $0.00 $0 D/D 1,209 79,289     -
   Zimmermann Martine Director   –       •      –    2025-06-06 4 D $105.99 $19,926 D/D (188) 4,558     -
   Zimmermann Martine Director   –       •      –    2025-06-06 4 A $0.00 $0 D/D 1,209 4,746     -
   Gray Nancy Ryan Director   –       •      –    2025-06-06 4 A $0.00 $0 D/D 1,209 8,094     -
   Sabba Stephen L Director   –       •      –    2025-06-06 4 A $0.00 $0 D/D 1,209 33,793     -
   Lamattina John L Director   –       •      –    2025-06-06 4 A $0.00 $0 D/D 1,209 30,724     -
   Kozarich John W Director   –       •      –    2025-06-06 4 A $0.00 $0 D/D 1,209 47,390     -
   Reardon Andrew CLO & Secretary   •       –      –    2025-05-15 4 S $104.00 $104,000 D/D (1,000) 32,903 -14%     
   Davis Todd C Chief Executive Officer   •       •      –    2025-05-09 4 B $104.53 $1,000,456 D/D 9,510 161,234 2.81 13%     
   Espinoza Octavio Chief Financial Officer   •       –      –    2025-05-09 4 B $103.89 $156,090 D/D 1,500 27,932 2.74 13%     
   Sabba Stephen L Director   –       •      –    2025-04-01 4 OE $52.30 $125,834 D/D 2,406 32,584     -
   Davis Todd C Chief Executive Officer   •       •      –    2025-03-04 4 A $0.00 $0 D/D 21,382 151,724     -
   Espinoza Octavio Chief Financial Officer   •       –      –    2025-03-04 4 A $0.00 $0 D/D 7,484 26,363     -
   Espinoza Octavio Chief Financial Officer   •       –      –    2025-03-04 4 S $115.03 $575,149 D/D (5,000) 18,879 -3%     
   Reardon Andrew CLO & Secretary   •       –      –    2025-03-04 4 A $0.00 $0 D/D 6,415 34,783     -
   Davis Todd C Chief Executive Officer   •       •      –    2025-02-15 4 D $120.00 $778,320 D/D (6,486) 130,342     -
   Espinoza Octavio Chief Financial Officer   •       –      –    2025-02-15 4 D $120.00 $363,240 D/D (3,027) 23,879     -
   Reardon Andrew CLO & Secretary   •       –      –    2025-02-15 4 D $120.00 $238,800 D/D (1,990) 28,368     -
   Davis Todd C Chief Executive Officer   •       •      –    2025-02-14 4 D $120.00 $835,920 D/D (6,966) 136,828     -
   Davis Todd C Chief Executive Officer   •       •      –    2025-02-14 4 A $0.00 $0 D/D 20,784 143,794     -
   Espinoza Octavio Chief Financial Officer   •       –      –    2025-02-14 4 D $120.00 $787,200 D/D (6,560) 26,906     -
   Espinoza Octavio Chief Financial Officer   •       –      –    2025-02-14 4 A $0.00 $0 D/D 12,819 30,709     -
  538 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us